




Wearable technology allows an in-depth analysis of gait 
behaviour in free-living environments. This investigation 
aimed to use Alzheimer’s disease as an example to apply 
the time series analysis technique of statistical parametric 
mapping (SPM) to create daily gait profiles and test if they 
differed from cognitively intact controls. A framework of 
macro (habitual walking behaviours) and micro 
characteristics (spatiotemporal gait variables) 
characteristics were calculated on an hourly basis. SPM 
showed that select micro gait characteristics differed from 
controls at specific hours of the day. Therefore, the 
application of SPM may provide a more in-depth 
reflection of activity and gait time-dependent fluctuations 
than commonly used whole day values. Considering macro 
and micro gait hour-by- hour may have applications 
towards disease management, personalized care, 
monitoring medication and targeted interventions for 
people with a range of neurodegenerative diseases. 
 
I. INTRODUCTION 
Evaluation of gait has traditionally been tested under 
controlled laboratory-based conditions [1]. Only recently, due 
to the advances in wearable technology (WT), has gait been 
examined in free-living (habitual/uncontrolled) environments 
[2], [3]. WT is capable of objectively and continuously 
quantifying clinically relevant outcomes unobtrusively for 
extended periods of time in the home and community [4]. 
Typically, these measures are summarised over the recording 
duration (e.g. 3 or 7 days) despite evidence that discrete gait 
and postural control measures can vary  when measured at set 
times of the day [5]. Continuously assessing gait may provide 
a more subtle reflection of activity and gait time-dependent 
fluctuations in addition to averaged values, or even, highlight 
time specific changes masked when averaged. Few examples 
exist where gait has been assessed on an hourly basis creating 
patterns of gait quantity/physical activity [3], [6] and, for novel 
acceleration specific measures indicative the multimodal 
relationship between gait cycle and vertical gait acceleration 
[7].  
Understanding how gait fluctuates throughout the day may 
provide novel insights of behavior in neurodegenerative 
diseases, such as AD. For example, if monitored continuously, 
sundown syndrome, where people with AD experience 
symptoms such as agitation, confusion, anxiety, pacing, 
wandering and hyperactivity in the late afternoon, evening or 
at night [8], may be highlighted by gait metrics. The time and 
duration of such a phenomena could therefore be better defined 
and consequently targeted. Equally because people with AD 
are at a greater risk of falling [9], gait variables indicative of 
falling risk may highlight when people with AD are at greatest 
risk. To our knowledge, a method to assess both measures 
indicative of behavioral walking activity and clinically relevant 
spatiotemporal measures of gait on an hourly basis has yet to 
be assessed continuously throughout the day for people with 
AD. 
An additional advantage of continuous monitoring of gait 
is that daily gait characteristics can be expressed as a time 
series, thus, opening the potential application of many time 
series analysis techniques. The use and comparison of time 
series techniques towards this goal is a methodological gap that 
if addressed could better unlock the potential of continuous 
monitoring of gait. For example, such techniques could 
describe how gait fluctuations occur differently from controls 
and at what time of day, and also take into account what 
happened prior and what happens after the hour of observation 
[10]. As such, the effect of factors such as fatigue or 
medication effect and their impact on subsequent activities 
may be taken into account.   
This study aims to apply Statistical Parametric Mapping 
(SPM) to daily gait time series to investigate the fluctuation of 
gait performance in people with AD relative to controls. The 
use of AD participants as an example cohort for this method 
and the examination of free-living gait data collected by WT 
could provide evidence that time series analysis techniques can 
highlight additional details indicative of unique signatures of 
both spatiotemporal and behavioral gait impairment 
fluctuations. Therefore, we propose that the application of 
creating a daily gait time series and then applying SPM, may 
contribute towards the integration and improvement of 
unobtrusive disease management, patient care and targeted 
interventions. 
II. METHODS 
A. Participants, protocol and data collection 
36 people with AD (age: 77±6 years, BMI: 26±4, 
standardised mini mental state exam (0-30): 23±4) and 26 (age: 
74 ± 9 years, BMI: 27±4, standardised mini mental state exam 
(0-30): 29±1) age matched control subjects were recruited. 
This study was conducted according to the declaration of 
Helsinki and had ethical approval from the Newcastle and 
North Tyneside research ethics committee (REC Reference: 
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16/NE/005). Participants were asked to wear a tri-axial 
accelerometer (Axivity AX3, York, UK) continuously on the 
lower back for one week. The water-proof device was 
programmed to capture data for seven days at 100Hz (16-bit 
resolution, range ± 8g). Participants were asked to continue 
their daily activities as usual and not to change their routine. 
Upon completion of recording, participants removed the 
device and posted it back to the researcher as detailed in 
previous work [11], [12]. 
B. Data Processing and Generation of Daily Gait Time 
Series 
Once the device was received, data were downloaded, 
segmented (per calendar day) and analysed using bespoke 
MATLAB® programs. For each day, a logical heuristics 
paradigm was embedded into walking bout identification and 
quantification algorithm which has shown to be accurate in 
detecting ambulatory bouts (ABs) and step count in free-living 
conditions [13]. Individual ABs were extracted via 
MATLAB®, where a ‘bout’ was defined as the continuous 
length of time spent walking with at least three consecutive 
steps. Ambulatory bouts were detected by applying selective 
thresholds on the triaxial acceleration data as detailed 
elsewhere [13]. 
Daily gait time-series of walking activity outcome 
measures were evaluated according to a broad framework of 
Macro and Micro characteristics [2], [11]. Macro (behavioral) 
outcomes included the volume (total walking time, percentage 
(%) of walking time, number of bouts and steps), mean AB 
length, and variability (S2) (estimated using a maximum 
likelihood technique) of ABs. A set of 14 clinically relevant 
Micro spatiotemporal gait characteristic were also determined 
for each walking bout. Characteristics were selected based 
upon a validated model of gait [2], [14]. Individual daily gait 
time series of Macro and Micro outcomes were generated 
based on the AB detected hourly from 00:00 to 24:00 and 
averaged across the 7 days. Due to insufficient walking periods 
> 3 steps in the late evening and early morning, the micro 
characteristics were analysed between 8am to 9pm in order to 
analyse a complete time series for each participant.  
B. SPM: Analysis of daily Gait Characteristics Time Series 
Profiles 
 Statistical parametric mapping (SPM) [15] was used to 
statistically compare daily gait characteristics time series 
profiles. SPM has been previously used for comparison of 
time series in the biomechanical field [10], [16].  Specifically, 
a SPM two-tailed independent t-test was used to compare 
walking activity and gait characteristics time series between 
control and AD groups (α=0.05). The scalar output statistic, 
SPM{t}, was calculated separately at each individual time 
node and is referred to as a Statistical Parametric Map. 
Conceptually, a SPM t-test is similar to the calculation and 
interpretation of a scalar t-test; if the SPM{t} trajectory 
crosses the critical threshold at any time node, the null 
hypothesis is rejected. Typically, due to waveform 
smoothness and the inter-dependence of neighbouring points, 
multiple adjacent points of the SPM{t} curve often exceed the 
critical threshold known as a “supra-threshold clusters”. SPM 
then uses Random Field Theory expectations regarding supra-
threshold cluster size to calculate cluster specific p-values 
which indicate the probability with which supra-threshold 
clusters could have been produced by a random field process 
with the same temporal smoothness [17]. All SPM analyses 
were implemented using the open-source spm1d code 
(v.M0.1, www.spm1d.org) in MATLAB® (R2015) [10]. 
III. RESULTS 
Table 1 indicates the time of the day when Macro and Micro 
gait variables time series significantly differ between AD 
group and HC. Time series of Macro characteristics were not 
significantly different between the two groups. For the Micro 
characteristics, step length and Step velocity time series 
differed from HC at three separate times of the day. Step, 
stance and swing time variability time series were 
significantly different between groups for one hour during the 
evening hours (between 18:00 and 20:00). 
Figure 1 highlights one example of Macro (total walk time) 
and one example Micro gait characteristic time series (mean 
step velocity) over a 24 and 12 hour time period respectively. 
Figure 1d highlights when mean step velocity was 
significantly different between groups. Three [supra-
threshold] clusters exceeded the critical threshold of   2.81 at 
the hours of 10–11, 14-15 and 18-19.  The probability of 
threshold clusters of these sizes would be observed in a 
random sampling of the same smoothness was p = 0.005, p = 
0.015 and p = 0.026, respectively. 
IV. DISCUSSION 
Results showed that when creating a time series 
representative of hourly gait characteristics it was feasible to 
apply SPM. This framework was able to highlight distinct 
differences between the AD and control group at specific times 
of day. Although showing trends where the macro 
characteristics differed between groups, only select micro 
characteristics reached significance. For this population, these 
results therefore support the collective macro and micro 
approach to provide a holistic picture of free-living gait. 
Previously, when assessing gait and posture at three time 
points of the day (11:00am, 14:00pm, 18:00pm), Paillard et al., 
[5] found that both gait and postural control was worse in the 
evening for people living with AD in care homes. They 
concluded the evening period was when the participants were 
at highest risk of falls and were linked to potential sundowning 
behaviours. Our community living results appear to reflect 
these findings as it was predominantly in the evening periods 
when the micro gait characteristics significantly differed from 
the controls.   It is beyond the scope of this exploratory paper 
Table 1. Indication of the variable where significant differences 
between groups was found and the time of day it occurred.  
 
Variable Time of threshold cluster and corresponding p value 
Mean Step Length 10–11 (p = 0.005), 13–14 (p = 0.015), 18-19 (p = 0.026) 
Mean Step Velocity 10-11 (p = 0.158), 14-15 (p = 0.041), 18-19 (p = 0.002) 
Step Time SD 18-19  (p = 0.029) 
Stance Time SD 19-20 (p = 0.008) 






to infer the altered gait characteristics relate to fall risk or 
potential sun down syndrome. However, significant 
impairments in the evening suggest use of SPM for identifying 
fluctuations throughout the day, which may have useful 
applications in AD, such as establishing “at-risk” fall periods, 
and targeted interventions. 
When assessing measures indicative of physical activity 
throughout the day, previous results have shown that people 
tend to be most active in the mornings and then decrease their 
activity throughout the day [3]. For people with AD it has been 
found that they replicate this pattern, but their activity peaks 
later in the morning and at a reduced amount relative to 
controls [3]. These results demonstrate similar behaviors. 
which may indicate they are attempting to manage the same 
amount of activity but over a sustained period [4]. 
Alternatively, the delayed and reduced activity may also 
indicate the reliance on a primary care giver who may impact 
the structure of activity of the person being cared for  [18]. 
Future work should explore for the interaction between diurnal 
activity profiles of the caregiver with those of the person being 
cared for. Although for these participants the behavioral 
measures did not reach significance between the groups, the 
framework of time series based profiles created on an hourly 
basis and the application of SPM provides opportunity to 
explore such relationships where average values of the whole 
day may not.  
In this paper, we provided an example of SPM to a small 
population of people living with AD and controls to assess 
daily gait time series profiles. The application of SPM in this 
context has many possible advantages for other 
neurodegenerative conditions. For example, for people with 
Parkinson’s disease, both macro and micro characteristics of 
gait may be influenced by medication intake and motor 
fluctuations i.e. periods with either a good levodopa therapy 
response (“ON” state) or periods when the medication effects 
wear off and motor symptoms re-emerge (“OFF” state) [6]. 
The framework of creating daylong gait timeseries for people 
with PD and the application of SPM appears ideally suited to 
monitor medication effectiveness and adjust dosage 
accordingly. Future research is warranted to apply SPM to the 
daily gait time series for people with PD while also monitoring 
medication intake. 
One limitation to the currently applied method was that not 
all participants had the sufficient number of walking bouts 
required to calculate micro gait metrics during the night; 
therefore, nighttime fluctuations could not be analysed. Sleep 
is likely to impact fluctuations both in cognition and mobility 
in AD, [3], and therefore, greater understanding of the 
relationship between sleep quality and gait behaviours would 
enhance interpretation of results. Future research should 
consider the application time series analysis to sleep-specific 
metrics in conjunction with gait analysis.  
 
 
Figure 1. One macro and micro gait example of a 24-hour and 12-hour time series respectively. For graph a and b, the red line represents the healthy 
controls and the blue line represents the Alzheimer’s group. Graphs c and d indicate the independent sample t-test SPM{t}. Critical threshold (3.20 and 
2.81 for c and d respectively, depicted by the dotted red line) was exceeded in d three times. The threshold was exceeded at hours 10-11, 14-15 and 18-
19 with [supra-threshold] cluster probabilities of p = 0.005, p = 0.015 and p = 0.026, respectively, indicating a reduced step velocity. 
  
The proposed framework where accelerometer based 
measures are divided into a daily time series and the 
application of a time series analysis technique is not limited to 
the macro and micro measures used in this example. Future 
research investigating a variety of additional gait measures and 
time series techniques is encouraged. This will allow for the 
comparison of how different time series created from different 
metrics relate to each other. For example, figure 2 provides 
opportunity to see how total walk time and gait velocity 
interact during the day and how this can differ between two 
populations. Such an approach when applied to different daily 
time series’ may provide an improved holistic understanding 
of free-living gait.  
V. CONCLUSION 
To our knowledge, this was the first application of SPM to 
analyse gait profiles presented as a time series throughout the 
day. Using the example of AD, results showed that gait 
characteristics differed at set hours of the day. The application 
of SPM may therefore help indicate when impairments occur 
and may contribute towards personalized care, disease 
management and targeted intervention strategies for people 
with AD. SPM used in this way provides additional detail 
advantageous in capturing how gait characteristics fluctuate 
during the course of the day. Therefore, it may have a range 
of healthcare applications towards care, disease management, 
monitoring effects of medication and applying targeted 
interventions. 
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Figure 2. An indication of how two separate daily time series can be 
explored relative to each other. Graph a) indicates the relationship of total 
walk time (blue) and step velocity (orange) for the control subjects and 
graph b) explains the same relationship for the Alzheimer’s group. 
